Literature DB >> 17005966

Alemtuzumab for refractory celiac disease.

Wieke H M Verbeek, Chris J J Mulder, Sonja Zweegman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17005966     DOI： 10.1056/NEJMc061784

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

Review 2.  Refractory celiac disease.

Authors:  Hani Abdallah; Daniel Leffler; Melinda Dennis; Ciarán P Kelly
Journal:  Curr Gastroenterol Rep       Date:  2007-10

3.  CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.

Authors:  Sheetal M Kircher; Sandeep Gurbuxani; Sonali M Smith
Journal:  J Gastrointest Cancer       Date:  2007

4.  CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.

Authors:  Sheetal M Kircher; Sandeep Gurbuxani; Sonali M Smith
Journal:  J Gastrointest Cancer       Date:  2007

Review 5.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Authors:  Greetje J Tack; Wieke H M Verbeek; Marco W J Schreurs; Chris J J Mulder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

6.  Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors:  V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal:  Clin Exp Immunol       Date:  2007-03-05       Impact factor: 4.330

Review 7.  Approach to patients with refractory coeliac disease.

Authors:  Ikram Nasr; Iman Nasr; Hannah Campling; Paul J Ciclitira
Journal:  F1000Res       Date:  2016-10-20

8.  Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.

Authors:  Ikram Nasr; Iman Nasr; Carl Beyers; Fuju Chang; Suzanne Donnelly; Paul J Ciclitira
Journal:  Nutrients       Date:  2015-12-01       Impact factor: 5.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.